Latest News

March 21, 2013
UCSF has named a highly accomplished pharmacist and clinical scientist, B. Joseph Guglielmo, PharmD, a 34-year member of the UCSF faculty, to lead the nation’s premier School of Pharmacy.
March 06, 2013
The Agency for Healthcare Research and Quality (AHRQ) has released a new report that identifies the top 10, evidence-based patient safety strategies available to clinicians.
June 29, 2012
As Thursday’s Supreme Court ruling on the health care law is examined, experts are citing concerns about the Medicaid decision, which could end up insuring fewer Americans as states opt out of expansion.
May 04, 2012
Academic medical centers can play a larger role in drug development and testing, according to an FDA official, who says there is a need for better strategies to identify winners, minimize costs and reduce failures during drug development.
January 26, 2012
John Corrin Hutchinson, MD, or “Hutch” to many, professor emeritus and Distinguished Fellow of the American College of Cardiology, passed away peacefully on Jan. 14, 2012. He was 84.
September 29, 2011
It’s a matter of fairness: members of all ethnic groups should have the opportunity to participate in clinical trials. And it’s a matter of soundness, too: medical advancements must be tested in as many different people with as many different genetic makeups as possible.
August 12, 2011
UC scientists explain radiation risks from everyday background radiation, medical imaging and nuclear power plant accidents in the aftermath of meltdowns at the Fukushima Daiichi nuclear power plant in Japan.
May 25, 2010
Diana Farmer, the world's first female fetal surgeon, shares her story from her early years as a self-described science geek to her current role as an advocate for high-quality patient care.
May 21, 2010
The cancer vaccine sipuleucel-T -- now commercially branded as Provenge -- will soon be available at a select group of medical centers nationwide, including UCSF.
March 03, 2010
New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.

Pages